Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Exploring the Role of Artificial Intelligence in Rheumatology

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  Issue: November 2022  |  November 4, 2022

Some intrepid researchers are starting to engage in this painstaking validation process. For certain purposes, such as predicting response to methotrexate in rheumatoid arthritis patients, AI has shown great promise.9 But when tasked with other high-stakes clinical decisions, such as predicting the diagnosis of ankylosing spondylitis, the results show a need for more refinement and validation.10

The precision of such technology will continue to advance, but what degree of imprecision will we be able to tolerate? After all,these are patients whose lives we are placing into the responsibility of computers with algorithms so convoluted their own programmers don’t know how they work.11 When a patient doesn’t quite fit into an algorithm, how will AI cope? And what are the legal and ethical ramifications of outsourcing our clinical decision making to a computer?12

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

These questions will need to be explored further as AI encroaches more and more upon the duties and tasks originally intended purely for humans.

The Robot Will See You Now

Even then, even if we reach the point that AI can reliably make clinical decisions, we will need to ponder the ramifications on our healthcare workforce. Per the ACR’s 2015 workforce assessment, there will be a deficit of more than 4,800 rheumatology providers by 2030.13 It is very well possible that sophisticated AI-based algorithms can help address this crisis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Existing rheumatology clinicians may be better able to use AI to automate burdensome and tedious tasks so direct patient care can be prioritized. Similarly, AI can help to support diagnostic decision making to facilitate care so that greater numbers of patients can be seen promptly. At its most ambitious, AI may support primary care providers identify those at risk for diagnostic delays or undertreatment, obviating even the need for a rheumatologist.14

But we’ve heard these sorts of promises before, with electronic health records (EHRs). And although EHRs have been quite helpful, the burden of documentation and administrative work has been a major driver of burnout, a contributor in and of itself to the workforce crisis.15 If clinicians and patients are not in the driver’s seat in programming and implementing AI for real-world clinical settings, I anticipate more administrative tasks, clicks and overall waste, furthering our burnout. And this doesn’t even get into the very real potential of clinicians having to complete prior authorizations and peer-to-peer requests through an AI-powered insurance robot.16

The Joints Were Right

We need more humanism

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Information TechnologyOpinionRheuminationsSpeak Out RheumTechnologyTechnology Tagged with:artificial intelligencebiasDiversity

Related Articles

    Artificial Intelligence in Medicine: The Future Is Now

    August 26, 2020

    Advancements in technology and artificial intelligence designed to aid rheumatologists in diagnosing patients and predicting mortality risk were discussed in depth during a session of the European e-Congress of Rheumatology.

    Rheumatology Research Foundation Helps Train Tomorrow’s Top Doctors

    August 10, 2016

    A passion to improve the clinical reasoning skills of future doctors led Maria Dall’Era, MD, associate professor of medicine and director of the University of California San Francisco (UCSF) Lupus Clinic, to create a revolutionary application for smartphones and tablets that could modernize medical education. With funding from the Rheumatology Research Foundation’s Clinician Scholar Educator…

    TrifonenkoIvan / shutterstock.com

    Artificial Intelligence Gives Rheumatologists an Assist

    June 14, 2021

    As the novel coronavirus that causes COVID-19 spreads across the globe, innovative thinking is needed more than ever to counter the devastating effects on the physical and socioeconomic health of individuals and communities. Innovations in healthcare delivery not yet fully realized prior to the pandemic, such as the adoption of telehealth, are moving to the…

    Lupus Treatment Advances Lag Behind Other Rheumatic Diseases

    August 11, 2016

    SAN FRANCISCO—In a presentation on advances in the treatment of systemic lupus erythematosus (SLE) at the California Rheumatology Alliance 2016 Medical & Scientific Meeting in May, Maria Dall’Era, MD, director of the Lupus Clinic and Rheumatology Clinical Research Center at the University of California, San Francisco, discussed the range of treatments that have been identified…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences